Literature DB >> 10943878

Magnetic resonance imaging detection of occult skin and subcutaneous abnormalities in juvenile dermatomyositis. Implications for diagnosis and therapy.

A B Kimball1, R M Summers, M Turner, E M Dugan, J Hicks, F W Miller, L G Rider.   

Abstract

OBJECTIVE: To assess the utility of magnetic resonance imaging (MRI) of skin, subcutaneous tissue, and fascia in evaluating disease activity in juvenile dermatomyositis (DM).
METHODS: Short tau inversion recovery (STIR) MRI of the proximal thighs and buttocks, cutaneous assessment, and other measures of disease activity were prospectively obtained in 26 children meeting criteria for probable or definite juvenile DM. Also undergoing STIR MRI assessment were 8 subjects who were being evaluated for muscle disorders and who were not diagnosed as having juvenile DM.
RESULTS: Skin, subcutaneous, or fascial edema of the thighs and buttocks were seen on STIR MRI in up to 85% of juvenile DM patients at baseline evaluation compared with no more than 38% of the comparison group without juvenile DM. In juvenile DM, STIR MRI skin and subcutaneous edema scores correlated (r(s) = 0.51, P = 0.008), as did fascial and muscle edema scores (r(s) = 0.58, P = 0.002). Skin global disease activity scores correlated with MRI skin edema scores (r(s) = 0.41, P = 0.04), and serum aldolase levels correlated with both MRI skin and subcutaneous edema scores (r = 0.44 and 0.40, P = 0.03 and 0.05 respectively). The extent and severity of STIR MRI changes in the skin, subcutaneous tissue, and fascia were not predicted by most other measures of juvenile DM disease activity. Five juvenile DM patients with thigh MRI subcutaneous edema developed clinically apparent calcinosis at the same location within 9 months.
CONCLUSION: Edema or inflammation in the skin, subcutaneous tissue, and fascia, found on STIR MRI, is common in juvenile DM patients and is often undetected by standard assessments. These MRI changes can precede the development of calcinosis. STIR MRI may be a useful adjunct for assessing disease activity and guiding the treatment of juvenile DM.

Entities:  

Mesh:

Year:  2000        PMID: 10943878     DOI: 10.1002/1529-0131(200008)43:8<1866::AID-ANR24>3.0.CO;2-6

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  18 in total

Review 1.  The presentation, assessment, pathogenesis, and treatment of calcinosis in juvenile dermatomyositis.

Authors:  Mark F Hoeltzel; Edward J Oberle; Angela Byun Robinson; Arunima Agarwal; Lisa G Rider
Journal:  Curr Rheumatol Rep       Date:  2014-12       Impact factor: 4.592

2.  Multi-parametric MRI characterization of healthy human thigh muscles at 3.0 T - relaxation, magnetization transfer, fat/water, and diffusion tensor imaging.

Authors:  Ke Li; Richard D Dortch; E Brian Welch; Nathan D Bryant; Amanda K W Buck; Theodore F Towse; Daniel F Gochberg; Mark D Does; Bruce M Damon; Jane H Park
Journal:  NMR Biomed       Date:  2014-07-26       Impact factor: 4.044

3.  Dermatomyositis: analysis of 109 patients surveyed at the Hospital das Clínicas (HCFMUSP), São Paulo, Brazil.

Authors:  Luciena Cegatto Martins Ortigosa; Vitor Manuel Silva dos Reis
Journal:  An Bras Dermatol       Date:  2014 Sep-Oct       Impact factor: 1.896

Review 4.  Whole-body MRI: non-oncological applications in paediatrics.

Authors:  Maria Beatrice Damasio; Francesca Magnaguagno; Giorgio Stagnaro
Journal:  Radiol Med       Date:  2016-02-19       Impact factor: 3.469

Review 5.  Amyopathic dermatomyositis.

Authors:  N J Olsen; J H Park; L E King
Journal:  Curr Rheumatol Rep       Date:  2001-08       Impact factor: 4.592

Review 6.  Osteoarthritis, application of physical therapy proceduers.

Authors:  Dijana Avdić; Dzemal Pecar; Emela Mujić-Skikić; Ehlimana Pecar
Journal:  Bosn J Basic Med Sci       Date:  2006-08       Impact factor: 3.363

Review 7.  Role of MRI in diagnosis and management of idiopathic inflammatory myopathies.

Authors:  Britta Maurer; Ulrich A Walker
Journal:  Curr Rheumatol Rep       Date:  2015-11       Impact factor: 4.592

Review 8.  Juvenile dermatomyositis: advances in pathogenesis, evaluation, and treatment.

Authors:  Adam M Huber
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

9.  Metabolic abnormalities and cardiovascular risk factors in children with myositis.

Authors:  Kathleen Coyle; Kristina I Rother; Martina Weise; Alaa Ahmed; Frederick W Miller; Lisa G Rider
Journal:  J Pediatr       Date:  2009-07-29       Impact factor: 4.406

Review 10.  Juvenile dermatomyositis: new developments in pathogenesis, assessment and treatment.

Authors:  Lucy R Wedderburn; Lisa G Rider
Journal:  Best Pract Res Clin Rheumatol       Date:  2009-10       Impact factor: 4.098

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.